Section Arrow
Quote
EXOZ.NASDAQ
- eXoZymes Inc
Quotes are at least 15-min delayed:2025/02/12 12:35 EST
Last
 15.85
-0.65 (-3.94%)
Day High 
17 
Prev. Close
16.5 
1-M High
-- 
Volume 
3.81K 
Bid
15.1
Ask
16.5
Day Low
15.31 
Open
16.99 
1-M Low
-- 
Market Cap 
157.23M 
Currency USD 
P/E -- 
%Yield -- 
10-SMA -- 
20-SMA -- 
50-SMA -- 
52-W High -- 
52-W Low -- 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-0.63/--
Enterprise Value
158.61M
Balance Sheet
Book Value Per Share
-0.38
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
--
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
XLOXilio Therapeutics1.399+0.742+112.94%-- 
ADTXAditxt Inc0.0965+0.0013+1.37%0PE
OCEAOcean Biomedical0.1838-0.0162-8.10%-- 
APTOAptose Biosciences0.228051+0.047951+26.62%-- 
WINTWindtree Therapeutics0.1724+0.0124+7.75%0.84PE
Quotes are at least 15-min delayed：2025/02/12 12:35 EST
Industry overview quotes are at least 15 minutes delayed
Business Description
Invizyne Technologies Inc is redefining biomanufacturing by leveraging cell-free multi-step enzyme-based systems to efficiently transform natural or renewable resources into highly sought-after chemicals. It believes that its biomanufacturing platform, known as SimplePath, will be a significant alternative to the current methods of chemical compound production, which are generally chemical synthesis, natural extraction, and synthetic biology. its objective with SimplePath isto enable the efficient production of a diverse range of chemicals, including pharmaceuticals, fuels, materials, food additives, and novel compounds. Its platform consists of a series of modular cascading enzyme-based biomanufacturing systems that leverage natural processes to perform complex chemical conversions.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.